Earnings History Data for Vascular Biogenics Ltd. (VBLT) - NYSE NASDAQ

To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.

For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.

See the full list of available companies here.

Vascular Biogenics Ltd.

Vascular Biogenics Ltd. is a clinical stage biotechnology company. It is focused on the discovery, development and commercialization of treatments for cancer and immune-inflammatory diseases. Its lead oncology candidate VB-111, is a gene-based biologic which is in Phase II clinical trials for the treatment of recurrent glioblastoma, an aggressive form of brain cancer. It is also developing VB-201, an oral small molecule that is in Phase II clinical trials for the treatment psoriasis and ulcerative colitis. Vascular Biogenics Ltd. is headquartered in Or Yehuda, Israel.

Release Date	Time	Est. Time	Symbol	Name	Market Cap (M)	Rep. EPS	Est. EPS	Last years EPS	SeekingAlpha Headline	Price	Change	Ext. Hours Price	Ext. Hours Change	52 Week Range	Volume	Avg. Volume	Ext. Hours Volume
15-05-2023	AH	4:05 PM ET (May 15)	VBLT	Vascular Biogenics Ltd.	14.64	-0.03	0.00	-0.13	VBL Therapeutics GAAP EPS of -$0.03 [5/15/2023 4:58 PM]	0.1959	0.0 (-2.05%)	0.20	0.0 (1.45%)	0.10 - 2.20	205,756	1,160,000	18,167
VBL Therapeutics GAAP EPS of -$0.03 [5/15/2023 4:58 PM]
14-11-2022	PM		VBLT	Vascular Biogenics	8.00	-0.12	-0.11	0.00	VBL Therapeutics GAAP EPS of -$0.12 in-line, revenue of $0.5M beats by $0.3M [11/15/2022 4:02 AM]	0.1328	0.01 (10.57%)	0.13	0.0 (4.16%)	0.11 - 2.53	2,752,379	680,000	50,875
VBL Therapeutics GAAP EPS of -$0.12 in-line, revenue of $0.5M beats by $0.3M [11/15/2022 4:02 AM] Vascular Biogenics (VBLT) Reports Q3 Loss, Tops Revenue Estimates [Nov-14-22 07:55PM] VBL Therapeutics Reports Third Quarter 2022 Financial Results and Provides Corporate Update [Nov-14-22 04:05PM]
17-05-2022	PM	7:00 AM ET (May 17)	VBLT	Vascular Biogenics	87.00	-0.13	-0.12	0.00	VBL Therapeutics GAAP EPS of -$0.13 misses by $0.01, revenue of $0.11M misses by $0.09M [5/17/2022 7:02 AM]	1.50	0.05 (3.08%)	0.0	0.0 (0.00%)	1.10 - 3.04	127,676	150,000	0
VBL Therapeutics Q1 2022 Earnings Preview [5/16/2022 12:42 PM] VBL Therapeutics GAAP EPS of -$0.13 misses by $0.01, revenue of $0.11M misses by $0.09M [5/17/2022 7:02 AM] Kala Pharmaceuticals (KALA) Reports Q1 Loss, Misses Revenue Estimates [May-16-22 08:15AM] VBL Therapeutics Reports First Quarter 2022 Financial Results and Provides Corporate Update [May-17-22 07:00AM] Vascular Biogenics (VBLT) Reports Q1 Loss, Misses Revenue Estimates [May-17-22 08:15AM]
23-03-2022	PM	7:30 AM ET (Mar 23)	VBLT	Vascular Biogenics Ltd.	103.25	-0.12	-0.08	-0.15	VBL Therapeutics GAAP EPS of -$0.45 misses by $0.03, revenue of $0.77M beats by $0.02M [3/23/2022 7:03 AM]	1.62	0.19 (12.95%)	0.0	0.0 (0.00%)	1.10 - 3.04	133,097	188,298	0
VBL Therapeutics GAAP EPS of -$0.45 misses by $0.03, revenue of $0.77M beats by $0.02M [3/23/2022 7:03 AM] VBL Therapeutics Reports Full Year 2021 Financial Results and Provides Corporate Update [Mar-23-22 07:00AM] Vascular Biogenics (VBLT) Reports Q4 Loss, Lags Revenue Estimates [Mar-23-22 09:25AM]
15-11-2021	PM	7:00 AM ET (Nov 15)	VBLT	Vascular Biogenics Ltd.	157.17	-0.09	-0.10	-0.12	VBL Therapeutics EPS beats by $0.01, beats on revenue [11/15/2021 7:38 AM]	2.40	-0.12 (-4.94%)	2.51	-0.02 (-0.79%)	1.15 - 3.17	357,125	170,000	32,723
VBL Therapeutics EPS beats by $0.01, beats on revenue [11/15/2021 7:38 AM] VBL Therapeutics Reports Third Quarter 2021 Financial Results and Provides Corporate Update [Nov-15-21 07:30AM] Vascular Biogenics (VBLT) Reports Q3 Loss, Lags Revenue Estimates [Nov-15-21 12:25PM]
16-08-2021	PM	7:00 AM ET (Aug 16)	VBLT	Vascular Biogenics Ltd.	131.42	-0.12	-0.10	-0.14	VBL Therapeutics EPS misses by $0.02, misses on revenue [8/16/2021 7:03 AM]	2.04	-0.21 (-9.33%)	2.20	-0.05 (-2.22%)	1.01 - 3.17	765,205	240,000	24,007
VBL Therapeutics EPS misses by $0.02, misses on revenue [8/16/2021 7:03 AM] VBL Therapeutics Reports Second Quarter 2021 Financial Results and Provides Corporate Update [Aug-16-21 07:00AM] Vascular Biogenics (VBLT) Reports Q2 Loss, Lags Revenue Estimates [Aug-16-21 08:25AM]
11-05-2021	PM	7:00 AM ET (May 11)	VBLT	Vascular Biogenics Ltd.	124.19	-0.12	-0.13	-0.15	VBL Therapeutics EPS beats by $0.01, misses on revenue [5/11/2021 7:02 AM]	2.02	0.01 (0.50%)	1.95	-0.06 (-2.99%)	1.01 - 3.17	284,163	900,000	12,627
VBL Therapeutics EPS beats by $0.01, misses on revenue [5/11/2021 7:02 AM] Vascular Biogenics Ltd. to Host Earnings Call [May-11-21 06:30AM] VBL Therapeutics Reports First Quarter 2021 Financial Results and Provides Corporate Update [May-11-21 07:00AM] Vascular Biogenics (VBLT) Reports Q1 Loss, Lags Revenue Estimates [May-11-21 08:35AM]
25-03-2021	PM	7:00 AM ET (Mar 25)	VBLT	Vascular Biogenics Ltd.	96.37	-0.15	-0.13	-0.16	VBL Therapeutics EPS misses by $0.02, misses on revenue [3/25/2021 7:10 AM]	2.05	0.10 (5.13%)	1.86	-0.09 (-4.62%)	1.01 - 3.17	181,127	300,000	15,328
VBL Therapeutics EPS misses by $0.02, misses on revenue [3/25/2021 7:10 AM] Vascular Biogenics Ltd. to Host Earnings Call [Mar-25-21 06:30AM] VBL Therapeutics Reports Fourth Quarter and Full Year 2020 Financial Results and Provides Corporate Update [Mar-25-21 07:00AM] Vascular Biogenics (VBLT) Reports Q4 Loss, Tops Revenue Estimates [Mar-25-21 08:15AM] Recap: Vascular Biogenics Q4 Earnings [Mar-25-21 07:39AM] Could The Vascular Biogenics Ltd. (NASDAQ:VBLT) Ownership Structure Tell Us Something Useful? [Mar-25-21 07:10AM]
16-11-2020	PM	7:00 AM ET (Nov 16)	VBLT	Vascular Biogenics Ltd.	53.17	-0.12	-0.13	-0.14	VBL Therapeutics EPS beats by $0.01, misses on revenue [11/16/2020 7:04 AM]	1.19	0.01 (0.84%)	1.24	0.06 (5.08%)	0.90 - 1.64	157,397	116,643	18,384

13-08-2020	PM	7:00 AM ET (Aug 13)	VBLT	Vascular Biogenics Ltd.	62.74	-0.14	-0.14	-0.13	VBL Therapeutics EPS in-line, misses on revenue [8/13/2020 7:06 AM]	1.27	-0.07 (-5.22%)	1.26	-0.08 (-5.97%)	0.90 - 1.64	155,292	355,099	4,480

14-05-2020	PM	7:00 AM ET (May 14)	VBLT	Vascular Biogenics Ltd.	45.55	-0.15	-0.16	-0.12	VBL Therapeutics EPS beats by $0.02, beats on revenue [5/14/2020 7:04 AM]	1.20	-0.02 (-1.64%)	1.23	0.01 (0.82%)	0.90 - 1.64	650,991	477,043	671